{
    "2020-07-17": [
        [
            {
                "time": "",
                "original_text": "从业绩预增看未来A股投资方向",
                "features": {
                    "keywords": [
                        "业绩预增",
                        "A股",
                        "投资方向"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物2020下半年投资策略：产业升级 关注医药核心价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "产业升级",
                        "核心价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "新冠肺炎检测板块大涨超3%，硕世生物、东方生物、乐普医药、复星医药、华大基因飙升",
                "features": {
                    "keywords": [
                        "新冠肺炎",
                        "检测板块",
                        "大涨",
                        "硕世生物",
                        "东方生物",
                        "乐普医药",
                        "复星医药",
                        "华大基因"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因帮助多哥建成“火眼”实验室",
                "features": {
                    "keywords": [
                        "华大基因",
                        "多哥",
                        "火眼实验室"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}